很好的app，能学到很多东西
加油
医线通
Published by:
Xi'an Xinma Interactive MediaLtd
Description
医线通——专注服务基层医生；
用医线通，考执业医师；
医线通是一款为提升基层医生诊疗技能，解决基层医生应试教育的视频培训APP；
内容均由中国工程院院士、三甲医院权威专家录制；
拥有西医诊疗、中医诊疗、实践操作、合理用药、应试教育、公共卫生等模块。
用医线通，考执业医师；
医线通是一款为提升基层医生诊疗技能，解决基层医生应试教育的视频培训APP；
内容均由中国工程院院士、三甲医院权威专家录制；
拥有西医诊疗、中医诊疗、实践操作、合理用药、应试教育、公共卫生等模块。
Screenshots
医线通 FAQ
-
Is 医线通 free?
Yes, 医线通 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 医线通 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 医线通 cost?
医线通 is free.
-
What is 医线通 revenue?
To get estimated revenue of 医线通 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Ukraine yet.
Ratings History
医线通 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
医线通 Installs
Last 30 days
医线通 Revenue
Last 30 days医线通 Revenue and Downloads
Gain valuable insights into 医线通 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Xi'an Xinma Interactive MediaLtd
- Languages
- Chinese
- Recent release
- 2.4.3 (5 months ago )
- Released on
- Jun 8, 2017 (7 years ago )
- Also available in
- China , Poland , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , Italy , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Algeria , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Dominican Republic , Argentina , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , India
- Last Updated
- 1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.